You are here: Home » Current Affairs » Coronavirus » News
Business Standard

US CDC advisors recommend Pfizer's Covid-19 vaccine for children aged 5-11

The vaccine is one-third the adult dose and the it would be given in two doses, three weeks apart. The lower dose was chosen to minimize side effects and still produce strong immunity, said Pfizer.

Topics
Pfizer | Coronavirus Vaccine

IANS  |  New York 

Rough estimates by public health experts suggest about 90 million partially vaccinated people in India are due for their second dose.
Vaccines

US children from 5 to 11 years old may soon be able to get a low-dose Covid-19 vaccine made by Pfizer-BioNTech, as advisors to the U.S. Centers for Disease Control and Prevention (CDC) voted unanimously to recommend the vaccine shots for this age group numbering around 28 million.

"If the recommendations are endorsed by CDC Director Rochelle Walensky, as expected, children could begin getting their shots within the next several days," reported National Public Radio (NPR).

The vaccine is one-third the adult dose and the vaccine would be given in two doses, three weeks apart. The lower dose was chosen to minimize side effects and still produce strong immunity, said

The US Food and Drug Administration (FDA) granted emergency use authorization of the vaccine in 5-11 years old on Friday. The FDA authorized a 10-microgram dose of Pfizer's vaccine in young children. The original shot given to those aged 12 and older is 30 micrograms, Xinhua news agency reported.

On Monday, White House Covid-19 Response Coordinator, Jeffrey Zients said the government has purchased enough of the low-dose children's vaccine for everyone in this age group.

The CDC's latest data show that 172 US children aged 5-11 have died from Covid-19 and more than 8,300 have been hospitalized.

--IANS

int/khz/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, November 03 2021. 07:46 IST
RECOMMENDED FOR YOU